Condition: Coronary Heart Disease (CHD) · Sponsor: Gan Lijun
This investigator-initiated, multicenter, open-label, randomized clinical trial evaluates the safety and efficacy of single antiplatelet therapy (SAPT) utilizing a P2Y12 inhibitor compared to dual antiplatelet therapy (DAPT) in the chronic coronary syndrome (CCS) and stable Acute Coronary Syndrome (S-ACS) patients undergoing percutaneous coronary intervention (PCI) with the latest generation rapamycin drug-coated balloon (DCB) without stent implantation. The study aims to assess rates of ischemic and bleeding adverse events.
This description comes directly from the study's public registry record.
Yong Cao · +86-0537-2905210 · caoyong0419@163.com
Always discuss trial participation with your own doctor first.
| Beijing Luhe Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| The First Affiliated Hospital of Hainan Medical University | Haikou, Hainan, China | Not Yet Recruiting |
| The 2nd Affiliated Hospital of Harbin Medical University | Harbin, Heilongjiang, China | Not Yet Recruiting |
| The Second Affiliated Hospital of Nanchang University | Nanchang, Jiangxi, China | Not Yet Recruiting |
| Heze Municipal Hospital | Heze, Shandong, China | Not Yet Recruiting |
| Shandong Provincial Hospital | Jinan, Shandong, China | Not Yet Recruiting |
| Shandong Provincial Third Hospital | Jinan, Shandong, China | Not Yet Recruiting |
| Affiliated Hospital of Jining Medical University | Jining, Shandong, China | Recruiting |
| Liaocheng People's Hospital | Liaocheng, Shandong, China | Not Yet Recruiting |
| Qingdao Municipal Hospital | Qingdao, Shandong, China | Not Yet Recruiting |
| Tai'an City Central Hospital | Tai’an, Shandong, China | Not Yet Recruiting |
| Zaozhuang Municipal Hospital | Zaozhuang, Shandong, China | Not Yet Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07587099